Dr. Crystal Proud, MD
Claim this profileChildren's Hospital of the King's Daughters
Studies Muscular Dystrophy
Studies Duchenne Muscular Dystrophy
15 reported clinical trials
15 drugs studied
Area of expertise
1Muscular Dystrophy
FKRP positive
LGMD2I/R9 positive
AAVrh74 antibody titers negative
2Duchenne Muscular Dystrophy
DMD positive
Duchenne mutation positive
exon 44 positive
Affiliated Hospitals
Children's Hospital Of The King's Daughters
Children's Hospital Of The King's Daughters
Clinical Trials Crystal Proud, MD is currently running
Gene Therapy
for Duchenne Muscular Dystrophy
The study will evaluate the safety and efficacy of delandistrogene moxeparvovec gene transfer therapy in non-ambulatory and ambulatory males with DMD. This is a randomized, double-blind, placebo-controlled 2-part study. Participants will be in the study for approximately 128 weeks. All participants will have the opportunity to receive intravenous (IV) delandistrogene moxeparvovec in either Part 1 or Part 2.
Recruiting1 award Phase 35 criteria
Satralizumab
for Duchenne Muscular Dystrophy
The purpose of this study is to assess the efficacy, safety, pharmacokinetics (PK) and pharmacodynamics (PD) of satralizumab, a humanized anti-interleukin-6 receptor (aIL-6R) monoclonal antibody, in ambulatory and non-ambulatory patients with Duchenne muscular dystrophy (DMD) age ≥ 8 to \< 16 years old receiving corticosteroid therapy.
Recruiting1 award Phase 28 criteria
More about Crystal Proud, MD
Clinical Trial Related1 year of experience running clinical trials · Led 15 trials as a Principal Investigator · 8 Active Clinical TrialsTreatments Crystal Proud, MD has experience with
- Placebo
- Nusinersen
- SRP-9001 (Delandistrogene Moxeparvovec)
- Pamrevlumab
- Corticosteroids
- OAV101
Breakdown of trials Crystal Proud, MD has run
Muscular Dystrophy
Duchenne Muscular Dystrophy
Muscular Atrophy
Spinal Muscular Atrophy
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Crystal Proud, MD specialize in?
Crystal Proud, MD focuses on Muscular Dystrophy and Duchenne Muscular Dystrophy. In particular, much of their work with Muscular Dystrophy has involved FKRP positive patients, or patients who are LGMD2I/R9 positive.
Is Crystal Proud, MD currently recruiting for clinical trials?
Yes, Crystal Proud, MD is currently recruiting for 5 clinical trials in Norfolk Virginia. If you're interested in participating, you should apply.
Are there any treatments that Crystal Proud, MD has studied deeply?
Yes, Crystal Proud, MD has studied treatments such as Placebo, Nusinersen, SRP-9001 (Delandistrogene Moxeparvovec).
What is the best way to schedule an appointment with Crystal Proud, MD?
Apply for one of the trials that Crystal Proud, MD is conducting.
What is the office address of Crystal Proud, MD?
The office of Crystal Proud, MD is located at: Children's Hospital of the King's Daughters, Norfolk, Virginia 23507 United States. This is the address for their practice at the Children's Hospital of the King's Daughters.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.